Literature DB >> 15282202

Sphingosine 1-phosphate reduces vascular leak in murine and canine models of acute lung injury.

Bryan J McVerry1, Xinqi Peng, Paul M Hassoun, Saad Sammani, Brett A Simon, Joe G N Garcia.   

Abstract

Excessive mechanical stress is a key component of ventilator-associated lung injury, resulting in profound vascular leak and an intense inflammatory response. To extend our in vitro observations concerning the barrier-protective effects of the lipid growth factor sphingosine 1-phosphate (Sph 1-P), we assessed the ability of Sph 1-P to prevent regional pulmonary edema accumulation in clinically relevant rodent and canine models of acute lung injury induced by combined intrabronchial endotoxin administration and high tidal volume mechanical ventilation. Intravenously delivered Sph 1-P significantly attenuated both alveolar and vascular barrier dysfunction while significantly reducing shunt formation associated with lung injury. Whole lung computed tomographic image analysis demonstrated the capability of Sph 1-P to abrogate significantly the accumulation of extravascular lung water evoked by 6-hour exposure to endotoxin. Axial density profiles and vertical density gradients localized the Sph 1-P response to transitional zones between aerated and consolidated lung regions. Together, these results indicate that Sph 1-P represents a novel therapeutic intervention for the prevention of pulmonary edema related to inflammatory injury and increased vascular permeability.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15282202     DOI: 10.1164/rccm.200405-684OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  101 in total

Review 1.  Role of G protein-coupled receptors in inflammation.

Authors:  Lei Sun; Richard D Ye
Journal:  Acta Pharmacol Sin       Date:  2012-02-27       Impact factor: 6.150

2.  FTY720-induced human pulmonary endothelial barrier enhancement is mediated by c-Abl.

Authors:  L Wang; E T Chiang; J T Simmons; J G N Garcia; S M Dudek
Journal:  Eur Respir J       Date:  2010-11-11       Impact factor: 16.671

3.  Sphingosine-1-phosphate prevents permeability increases via activation of endothelial sphingosine-1-phosphate receptor 1 in rat venules.

Authors:  Gengqian Zhang; Sulei Xu; Yan Qian; Pingnian He
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-08-20       Impact factor: 4.733

4.  Transient receptor potential channel 1 maintains adherens junction plasticity by suppressing sphingosine kinase 1 expression to induce endothelial hyperpermeability.

Authors:  Mohammad Tauseef; Mohammad Farazuddin; Sukriti Sukriti; Charu Rajput; James Otto Meyer; Suresh Kumar Ramasamy; Dolly Mehta
Journal:  FASEB J       Date:  2015-08-27       Impact factor: 5.191

5.  Pulmonary endothelial cell barrier enhancement by novel FTY720 analogs: methoxy-FTY720, fluoro-FTY720, and β-glucuronide-FTY720.

Authors:  Sara M Camp; Eddie T Chiang; Chaode Sun; Peter V Usatyuk; Robert Bittman; Viswanathan Natarajan; Joe G N Garcia; Steven M Dudek
Journal:  Chem Phys Lipids       Date:  2015-08-10       Impact factor: 3.329

6.  Role of vascular and lymphatic endothelial cells in hantavirus pulmonary syndrome suggests targeted therapeutic approaches.

Authors:  Erich R Mackow; Elena E Gorbunova; Nadine A Dalrymple; Irina N Gavrilovskaya
Journal:  Lymphat Res Biol       Date:  2013-09-11       Impact factor: 2.589

Review 7.  Endothelial FAK as a therapeutic target in disease.

Authors:  Giovanni A Infusino; Jeffrey R Jacobson
Journal:  Microvasc Res       Date:  2011-10-06       Impact factor: 3.514

Review 8.  Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management.

Authors:  Michael A Matthay; Guy A Zimmerman
Journal:  Am J Respir Cell Mol Biol       Date:  2005-10       Impact factor: 6.914

Review 9.  Lung transplantation: opportunities for research and clinical advancement.

Authors:  David S Wilkes; Thomas M Egan; Herbert Y Reynolds
Journal:  Am J Respir Crit Care Med       Date:  2005-07-14       Impact factor: 21.405

10.  Leukotrienes in acute lung injury: a potential therapeutic target?

Authors:  James A Frank; Michael A Matthay
Journal:  Am J Respir Crit Care Med       Date:  2005-08-01       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.